Prana Biotechnology Ltd(PBT)

Description: Prana Biotechnology Limited researches and develops therapeutic drugs for the treatment of Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidates include PBT434 that is in Phase I clinical trial for the treatment for Parkinson's disease and other movement disorders; and PBT2, which has completed four Phase I studies and a Phase IIa clinical trial for patients with Alzheimer's disease. It also completed the IMAGINE Phase II biomarker imaging trial in Alzheimer's disease; and a open label IMAGINE Extension study and the Reach2HD Phase IIa trial in Huntington disease. The company was founded in 1997 and is based in Melbourne, Australia.

---

Keywords: Medicine Biotechnology Clinical Medicine Disease Drugs Imaging Clinical Trial Alzheimer's Disease Parkinson's Disease Disorders Neurological Disorders Psychiatric Diagnosis Chloroarenes Neurology Treatment Of Alzheimer's Disease Movement Disorders Huntington Disease Pbt2 Pbt434 Therapeutic Drugs

---

Home Page: pranabio.com

PBT Technical Analysis

Exchange: AU

Country: AU

Currency: Australian Dollar (A$)